Tenon Medical (TNON) Regains Nasdaq Compliance

Tenon Medical, Inc. (NASDAQ: TNON) today announced that it is in compliance with all relevant Nasdaq continued listing Rules. The Company had previously reported non compliance with Nasdaq Rules 5605(b)(1), 5605(c)(2) and 5605(d)(2), with respect to the number of independent directors on its board of directors and certain board committees; Nasdaq Rule 5550(a)(2), with respect to its minimum bid price; Nasdaq Rule 5550(a)(4), with respect to number of shares in its public float; and Nasdaq Rule 5550(b), with respect to its stockholders' equity. The Company has received written confirmation from Nasdaq that it has regained compliance with each previously reported non-compliance of Nasdaq listing Rules.

You May Also Be Interested In

• EU approves Acadia's trofinetide for Rett syndrome treatment
• BTIG Starts Reformation Inc (REF) at Buy
• Guggenheim Starts Jersey Mike's Subs (JMKE) at Buy